# Effects of Antiviral Therapy on HBV Reactivation

> **NCT02829359** · PHASE2,PHASE3 · COMPLETED · sponsor: **Guangxi Medical University** · enrollment: 200 (actual)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** Entecavir therapy

## Key facts

- **NCT ID:** NCT02829359
- **Lead sponsor:** Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02829359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02829359, "Effects of Antiviral Therapy on HBV Reactivation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02829359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*